Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

NCT03911401 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: 0.3% OPA-15406
DRUG: 1% OPA-15406
DRUG: Placebos

Sponsor

Otsuka Pharmaceutical Co., Ltd.